• Reframe Daily
  • Posts
  • Reframe Daily: ROS1 cancer pill, combo COVID-flu shot & instant doctor booking

Reframe Daily: ROS1 cancer pill, combo COVID-flu shot & instant doctor booking

Good healthcare news on 2025-06-11. I checked credible sources for you, assessed their market impact, and filtered out the bad stuff. Estimated reading time saved: 1.85 hours. Check here for all past issues.

Let me know how to make this newsletter more useful to you! I read every email.

- Christin Chong (neuroscience PhD, chaplain, healthcare marketer, at your service)

Headline

Why it’s good news

Market-readiness¹

FDA approves first ROS1 lung-cancer pill Ibtrozi

Doctors and patients now have a pill that can target a rare lung-cancer gene, so treatment can start fast and doesn’t need an IV drip. 

😊😊😊😊😊

Novavax’s combo COVID-flu shot shows a strong immune boost in late-stage study

One shot could guard against both COVID-19 and the flu, which would mean fewer needles and better protection each winter. 

😊😊😊

Blue Shield of California links up with Zocdoc so members can book in-person visits online

Millions of people can now see real-time doctor openings and book an appointment in seconds instead of calling around. 

😊😊😊😊😊

NeuroFlow rolls out new analytics that flag mental-health risks sooner

The software helps clinics spot patients who might be depressed or anxious early, so they can get help before problems grow. 

😊😊😊😊

Scientists crack the last genes needed to make Taxol in plants

This lab discovery could let factories grow a key cancer drug instead of chopping yew trees, making the medicine cheaper and greener someday. 

😊

😊 = lab stage 😊😊 = early pilot 😊😊😊 = late trial 
😊😊😊😊 = just approved/rolling out 😊😊😊😊😊 = on the market

P.S. Want to take charge of your health in a fun community and study yourself like a compassionate scientist? Schedule a chat with me to see if the reframe science is right for you!